Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

PDL Biopharma



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
The average size of a deal this fund participated in
Portfolio companies 7
Rounds per year 0.29
Lead investments 3
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 5
Key employees Soon

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Pharmaceutical

In 1986 was created PDL Biopharma, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Incline Village. The venture was found in North America in United States.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the PDL Biopharma, startups are often financed by VantagePoint Capital Partners, Spray Venture Partners, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are Aisling Capital, Florida Opportunity Fund, Florida Growth Fund. In the next rounds fund is usually obtained by Aisling Capital, Saints Capital, SV Health Investors.

Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 50 - 100 millions dollars. Opposing the other organizations, this PDL Biopharma works on 21 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2018.

The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Evofem Biosciences, kaleo, Direct Flow Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Women's, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of PDL Biopharma:
Typical Co-investors
PDL Biopharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after PDL Biopharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acario Innovation California, Menlo Park, United States
ASU Innovation Open -
CI Financial Inc Canada, Ontario, Toronto
CITIC Medical Fund -
Crimson Capital Czechia, Prague, Prague
Deguang Shengan Beijing, China, Haidian
Fashion 22 -
Gaia Securitizations -
Galam -
Huckletree Alpha Programme London England, London, United Kingdom
JIG-SAW Chiyoda, Japan
Magnetic Ventures -
MC2 -
MCube8 -
Moken British Columbia, Canada, Vancouver
Mucker Capital California, Santa Monica, United States
Sarava Iran, Tehran, Tehran County
Supreme Group Dubai, United Arab Emirates


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent PDL Biopharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 64M
Rounds per year 0.29
Peak activity year 2013
Lead investments 3
Follow on index 0.30
Exits 5
Group Appearance index 0.30
Crunchbase icon

Content report

The following text will be sent to our editors: